首页 › 基金 › NWI MANAGEMENT LP › ABVX

NWI MANAGEMENT LP 对 ABVX 的持仓历史

ABIVAX SA · 医疗保健

NWI MANAGEMENT LP 在 Q2 2026 的 13F 申报中披露持有 ABVX(ABIVAX SA)72,000 股,市值约 US$9.6M,约占其申报组合的 0.57%,在其申报持仓中市值排名第 30 位。 NWI MANAGEMENT LP 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)72.00K 股
申报持仓市值$9.60M
组合权重0.57%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

NWI MANAGEMENT LP 对 ABVX 的持仓演变

NWI MANAGEMENT LP 于 Q2 2026 首次披露 ABVX 持仓:72,000 股(约 US$9.6M)。

逐季持仓明细

季度股数金额变化
Q2 2026 72.00K $9.60M 新进

关于 ABVX 与 13F 数据

ABVX(ABIVAX SA)属于医疗保健行业。我们追踪的基金中还有 73 只申报持有 ABVX,申报仓位最大的包括:TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ABVX 的基金

查看 ABVX 的全部基金持有人 →

常见问题

How long has NWI MANAGEMENT LP held ABVX?

NWI MANAGEMENT LP has disclosed ABVX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is NWI MANAGEMENT LP's current position in ABVX?

As of Q2 2026, NWI MANAGEMENT LP holds 72.00K shares of ABVX (ABIVAX SA), valued at $9.60M, representing 0.57% of its reported portfolio and ranking #30.

Has NWI MANAGEMENT LP been buying or selling ABVX?

In the latest 13F filing (Q2 2026), NWI MANAGEMENT LP newly opened its position in ABVX.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.